BACHEM
Live / Registered — Registered — international registration renewed (as of 22 Mar 2021)
What this means for you
Registered since 26 May 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79147297
- Registration number
- 4741291
- Mark type
- Word mark
- Filed
- 08 Apr 2014
- Published for opposition
- 10 Mar 2015
- Registered
- 26 May 2015
- Attorney of record
- Alex R Sluzas
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science, namely, amino acids, peptides, reagents for peptide synthesis, amino acid derivatives, cytokines, enzyme inhibitors, enzyme substrates, growth factors, peptide substrates, all for use as scientific and laboratory research reagents in the field of medicine and molecular biology; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; chemical products used for preserving foodstuffs
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary products, namely, pharmaceutical preparations for use in the treatment of bleeding, premature labor, pulmonary hypertension, erectile disfunction, coronary syndromes, prostate cancer, endometriosis, central precocious puberty, uterine myoma, osteoporosis, hypercalcernia, Paget's disease, reflex sympathetic dystrophy, nocturnal enureses, central diabetes insipidus, polyuria, polydipsia, hemophilia A, von Willebrand disease, unstable angina, myocardial infarction, hypoglycemia, ovarian follicular cysts, cryptochism, breast cancer, growth hormone deficiency, acromegaly, carcinoid syndrome, thyrotrophic adenomas, diabetes II, VIPosmas, ulcer bleeding, hemorrhagic gastritis, postoperative pancreatic and duodenal fistulae, variceal hemorrhage, neurological diseases, rheumatic diseases, skin diseases, diseases of the intestinal tract, cancer, conjunctivitis, glaucoma, ocular hypertension, Parkinson's disease, transfusion-induced hemosiderosis, candidasis, dermatophytosis, pityriasis, congenital homocystinuria, hyperammonaemia, hepatic encephalopathy, ischemic heart disease, chorioretinal vascular disorders, hypertension, endema, insomnia, bipolar disorder, and schizophrenia; pharmaceutical preparations for use in the diagnosis of gastrinoma; veterinary preparations for use in the induction of ovulation in estrous mares, and reproduction control in dogs and cats; pharmaceutical preparations for use in the diagnosis of Cushing's syndrome, hypothalamic-pituitary-gonadal axis function, growth hormone deficiency, pancreatic exocrine dysfunction, gastrinoma, and adrenocortical insufficiency; dietetic food and substances for medical or veterinary use, namely, taste-modulating food additives in the nature of peptides for medical use, appetite suppressors for medical use; food supplements for humans and animals; fungicides; herbicides
Owner
- Bachem Holding AG, Bubendorf, CH
- Bachem Holding AG, CH
- Bachem Holding AG, CH
Prior registrations
Prosecution history
- 12 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 30 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Jul 2025 — PROOF OF USE INTERIM ACTION ISSUED
- 10 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 May 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 25 Jun 2024 — OFFICE ACTION ISSUED POU1
- 25 Jun 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jun 2024 — TEAS SECTION 71 RECEIVED
- 26 May 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 18 Apr 2024 — INTERNATIONAL REGISTRATION RENEWED
- 22 Mar 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 22 Mar 2021 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 22 Mar 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Feb 2021 — TEAS SECTION 71 & 15 RECEIVED